Evoq Remedies

3.07
+0.06
(1.99%)
Market Cap
7.65 Cr
EPS
0.03
PE Ratio
75.25
Dividend Yield
0.00 %
52 Week High
12.28
52 Week Low
2.11
PB Ratio
0.17
Debt to Equity
0.28
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
224.37
#1 17,540.67
14.16
#1 89,609.60
12.69
#1 1,239
15.84
51.71
55.74
8,361.00
51.84
204.30
-94.36
192
-93.36
54.20
541.20
3,810.05
21.07
961.40
9.35
204
401.80
57.02
73.30
2,461.08
487.22
70.60
-9.60
3
-12.50
47.76
123.94
2,213.00
-
146.40
-48.78
-51
450.00
53.08
143.05
1,398.61
80.07
7.10
#1 8,85,900.00
-3
876.92
64.09
390.00
1,391.21
48.46
78.10
6,408.33
20
-1.89
40.57
102.94
1,381.81
26.47
12.60
-76.62
2
#1 22,050.00
77.18
101.00
1,241.12
43.91
131.90
108.37
12
247.22
60.97
38,916.90
1,196.16
#1 8.94
80.80
15.93
124
-65.60
56.77
Growth Rate
Revenue Growth
-76.14 %
Net Income Growth
-68.75 %
Cash Flow Change
222.30 %
ROE
-72.59 %
ROCE
-73.75 %
EBITDA Margin (Avg.)
13.15 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
TTM
Revenue
3
9
10
17
26
6
0
Expenses
3
9
9
15
24
6
0
EBITDA
0
0
1
2
2
1
0
Operating Profit %
1 %
0 %
10 %
9 %
-18 %
-40 %
0 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
2
2
1
0
Tax
0
0
0
0
1
0
0
Net Profit
0
0
1
1
2
1
0
EPS in ₹
0.16
0.00
715.00
0.70
1.19
0.03
0.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
2
6
8
33
35
37
Fixed Assets
0
0
0
0
0
0
Current Assets
2
6
8
33
35
37
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
0
0
0
0
Other Assets
2
6
8
33
35
37
Total Liabilities
2
6
8
33
35
37
Current Liabilities
2
6
7
10
10
12
Non Current Liabilities
0
0
0
0
0
0
Total Equity
0
0
1
23
25
25
Reserve & Surplus
0
0
1
10
11
12
Share Capital
0
0
0
14
14
14

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
3
-3
0
Investing Activities
0
0
0
0
0
0
Operating Activities
0
0
0
-26
-4
5
Financing Activities
0
0
0
30
1
-5

Share Holding

% Holding
Feb 2022
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
100.00 %
73.53 %
73.53 %
73.53 %
73.53 %
20.53 %
11.21 %
11.21 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
23.06 %
24.56 %
25.21 %
24.91 %
73.38 %
85.57 %
85.75 %
Others
0.00 %
3.41 %
1.91 %
1.26 %
1.56 %
6.09 %
3.21 %
3.04 %
No of Share Holders
7
827
727
707
727
1,672
1,588
1,577

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Board Meeting Intimation for Intimation Of Board Meeting Of The Company3 days ago
Board Meeting Outcome for Outcome And Intimation Of Board Meeting Of The Company3 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
Board Meeting Intimation for Calling Of Board Meeting On Friday 18Th April 2025 At 03:00 P.M.Apr 10, 2025
Integrated Filing (Financial)Apr 10, 2025
Submission Of Results For The Half Year And Year Ended On 31St March 2025Apr 10, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 10Th April 2025Apr 10, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 10Th April 2025Apr 03, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 10Th April 2025Apr 03, 2025
Closure of Trading WindowMar 29, 2025
Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September 2024 Along With Limited Review ReportMar 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 3Rd March 2025Mar 03, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 20, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJan 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 21St January 2025 Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJan 10, 2025
Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousre Requirements) Regulations, 2015Dec 16, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 28, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Announcement Under Regulation 30 - General AnnouncementOct 01, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 01, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateOct 01, 2024
Board Meeting Outcome for Outcome Under Regulation 30 Of SEBI (Listing Obligations And DisclosureRequirements) Regulations, 2015Oct 01, 2024
Submission Of Voting Result Of The Annual General MeetingOct 01, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 28, 2024
Submission Of Annual Report For Financial Year 2023-24Sep 06, 2024
Reg. 34 (1) Annual Report.Sep 06, 2024
Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015Sep 06, 2024
Outcome Of Board Meeting And Intimation As Per Regulation 30 Of SEBI (LODR) Regulation, 2015Sep 06, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting And Intimation As Per Regulation 30 Of SEBI (LODR) Regulation, 2015Sep 06, 2024
Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorAug 01, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 01, 2024
Board Meeting Outcome for Outcome Under Regulation 30 Of SEBI (Listing Obligations And DisclosureRequirements) Regulations, 2015Aug 01, 2024
Announcement under Regulation 30 (LODR)-Preferential IssueAug 01, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 13, 2024
Submission Of Revised Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S ReportJul 12, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 22Nd June, 2024Jun 22, 2024
Intimation Of In-Principle Approval Received For Issue And Allotment Upto 1,13,00,000 Equity Shares By Evoq Remedies Limited ('The Company') Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.Jun 11, 2024
Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S ReportMay 27, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 27Th May, 2024May 27, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 27Th May, 2024May 20, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024Apr 30, 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024Apr 27, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 15, 2024
Clarification Sought On Significant Movement In PriceApr 11, 2024

Technical Indicators

RSI(14)
Neutral
47.14
ATR(14)
Less Volatile
0.14
STOCH(9,6)
Overbought
94.91
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.17
ADX(14)
Weak Trend
13.26
UO(9)
Bearish
80.83
ROC(12)
Uptrend And Accelerating
15.33
WillR(14)
Overbought
0.00